Anticancer alkaloid lamellarins inhibit protein kinases

Marine Drugs

Volumn 6, Issue 4, 2008, Pages 514-527

  Baunbæk, Dianne ^a   Trinkler, Nolwenn ^a   Ferandin, Yoan ^a   Lozach, Olivier ^a   Ploypradith, Poonsakdi ^b   Rucirawat, Somsak ^b   Ishibashi, Fumito ^d   Iwao, Masatomo ^c   Meijer, Laurent ^a  

^a STATION BIOLOGIQUE   (France)

^b Toxicology and Management of Chemicals   (Thailand)

^c NAGASAKI UNIVERSITY   (Japan)

^d NONE

Author keywords

CK1; Cyclin dependent kinases; DYRK 1A; GSK 3; Kinase inhibitor; Lamellarin

Indexed keywords

ANTINEOPLASTIC AGENT; CASEIN KINASE I; CYCLIN DEPENDENT KINASE; DI H LAMELLARIN D; DI H LAMELLARIN H; GLYCOGEN SYNTHASE KINASE 3; LAMELLARIN 11; LAMELLARIN 12; LAMELLARIN 3; LAMELLARIN 31; LAMELLARIN 32; LAMELLARIN 33; LAMELLARIN 34; LAMELLARIN 4; LAMELLARIN 5; LAMELLARIN 6; LAMELLARIN 7; LAMELLARIN 8; LAMELLARIN 9; LAMELLARIN ALPHA; LAMELLARIN D; LAMELLARIN G; LAMELLARIN H; LAMELLARIN K; LAMELLARIN L; LAMELLARIN N; PROTEIN KINASE PIM 1; PROTEIN TYROSINE KINASE A; UNCLASSIFIED DRUG;

ARTICLE; BIOLOGICAL ACTIVITY; CELL DEATH; CYTOTOXICITY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG SELECTIVITY; DRUG STRUCTURE; ENZYME INHIBITION; HUMAN; IC 50; STRUCTURE ACTIVITY RELATION;

INVERTEBRATA;

EID: 57149097315     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md20080026     Document Type: Article

References (44)

1. Bourguet-Kondracki, M.L.; Kornprobst, J.M. Marine pharmacology: potentialities in the treatment of infectious diseases, osteoporosis and Alzheimer's disease. Adv. Biochem. Eng. Biotechnol. 2005, 97, 105-131.
2. Simmons, T.L.; Andrianasolo, E.; McPhail, K.; Flatt, P.; Gerwick, W.H. Marine natural products as anticancer drugs. Mol. Cancer Ther. 2005, 4, 333-342.
3. Cironi, P.; Albericio, F.; Alvarez, M. Lamellarins: isolation, activity and synthesis, Progr. Heterocycl. Chem. 2004, 16, 1-26.
4. Bailly, C. Lamellarins, from A to Z: a family of anticancer marine pyrrole alkaloids. Curr. Med. Chem. Anti-Cancer Agents 2004, 4, 363-378.
5. Fan, R.H.; Peng, J.; Hamann, M.T.; Hu, J.F. Lamellarins and related pyrrole-derived alakaloids from marine organisms. Chem. Rev. 2008, 108, 264-287.
6. Andersen, R.J.; Faulkner, D.J.: He, C.H.; Van Duyne, G.D.; Clardy, J. Metabolites of the marine prosobranch mollusk Lamellaria sp. J. Am. Chem. Soc. 1985, 107, 5492-5495.
7. Lindquist, N.; Fenical, W.; Van Duyne, G.D.; Clardy, J. New alkaloids of the lamellarin class from the marine ascidian Didemnum chartaceum (Sluiter, 1909). J. Org. Chem. 1988, 53, 4570-4574.
8. Carroll, A.R.; Bowden, B.F.; Coll, J.C. Studies of Australian ascidians. I. Six new lamellarin-class alkaloids from a colonial ascidian, Didemnum sp. Austr. J. Chem. 1993, 46, 489-501.
9. Urban, S.; Capon, R.J. Lamellarin S: A New Aromatic Metabolite from an Australian Tunicate Didemnum sp. Aust. J. Chem. 1996, 49, 711-713.
10. Reddy, M.V.R.; Faulkner, D.J.; Venkateswarlu, Y.; Rao, M.R. New lamellarin alkaloids from an unidentified ascidian from the Arabian Sea. Tetrahedron 1997, 53, 3457-3466.
11. Davis, R.A.; Carroll, A.R.; Pierens, G.K.; Quinn, R.J. New lamellarin alkaloids from the australian ascidian, Didemnum chartaceum. J. Nat. Prod. 1999, 62, 419-424.
12. Ham, J.; Kang, H. A novel cytotoxic alkaloid of lamellarin class from a marine ascidian Didemnum sp. Bull. Korean Chem. Soc. 2002, 23, 163-166.
13. Reddy, S.M.; Srinivasulu, M.; Satyanarayana, N.; Kondapi, A.K.; Venkateswarlu, Y. New potent cytotoxic lamellarin alkaloids from Indian ascidian Didemnum obscurum. Tetrahedron 2005, 61, 9242-9247.
14. Reddy, M.V.; Rao, M.R.; Rhodes, D.; Hansen, M.S.; Rubins, K.; Bushman, F.D.; Venkateswarlu, Y.; Faulkner, D.J. Lamellarin alpha 20-sulfate, an inhibitor of HIV-1 integrase active against HIV-1 virus in cell culture. J. Med. Chem. 1999, 42, 1901-1907.
15. Urban, S.; Butler, M.S.; Capon, R.J. Lamellarins O and P: New Aromatic Metabolites from the Australian Marine Sponge Dendrilla cactos. Aust. J. Chem. 1994, 47, 1919-1924.
16. Urban, S.; Hobbs, L.; Hooper, J.N.A.; Capon, R.J. Lamellarins Q and R: New Aromatic Metabolites from an Australian Marine Sponge Dendrilla cactos. Aust. J. Chem. 1995, 48, 1491-1494.
17. Quesada, A.R.; Garcia Gravalos, M.D.; J.L. Fernandez Puentes Polyaromatic alkaloids from marine invertebrates as cytotoxic compounds and inhibitors of multidrug resistance caused by P-glycoprotein, Br. J. Cancer, 1996, 74, 677-682.
18. F. Ishibashi, S. Tanabe, T. Oda, M. Iwao, Synthesis and structure-activity relationship study of lamellarin derivatives, J. Nat. Prod., 2002, 65, 500-504.
19. M. Facompre, C. Tardy, C. Bal-Mahieu, P. Colson, C. Perez, I. Manzanares, C. Cuevas, C. Bailly, Lamellarin D: a novel potent inhibitor of topoisomerase I, Cancer Res., 2003, 63, 7392-7399.
20. C. Tardy, M. Facompre, W. Laine, B. Baldeyrou, D. Garcia-Gravalos, A. Francesch, C. Mateo, A. Pastor, J.A. Jimenez, I. Manzanares, C. Cuevas, C. Bailly, Topoisomerase I-mediated DNA cleavage as a guide to the development of antitumor agents derived from the marine alkaloid lamellarin D: trimethylester derivatives incorporating amino acid residues, Bioorg. Med. Chem., 2004, 12, 1697-1712.
21. E. Marco, W. Laine, C. Tardy, A. Lansiaux, M. Iwao, F. Ishibashi, C. Bailly, F. Gago, Molecular determinants of topoisomerase I poisoning by lamellarins: comparison with camptothecin and structure-activity relationships, J. Med. Chem., 2005, 48, 3796-3807.
22. M. Vanhuyse, J. Kluza, C. Tardy, G. Otero, C. Cuevas, C. Bailly, A. Lansiaux,. Lamellarin D: a novel pro-apoptotic agent from marine origin insensitive to P-glycoprotein-mediated drug efflux, Cancer Lett., 2005, 22, 165-175.
23. J. Kluza, M.A. Gallego, A. Loyens, J.C. Beauvillain, J.M. Sousa-Faro, C. Cuevas, P. Marchetti, C. Bailly, Cancer cell mitochondria are direct proapoptotic targets for the marine antitumor drug lamellarin D, Cancer Res., 2006, 66, 3177-3187.
24. M.A. Gallego, C. Ballot, J. Kluza, N. Hajji, A. Martoriati, L. Castéra, C. Cuevas, P. Formstecher, B. Joseph, G. Kroemer, C. Bailly, P. Marchetti, Overcoming chemoresistance of non-small cell lung carcinoma through restoration of an AIF-dependent apoptotic pathway, Oncogene, 2008, 27, 1981-1992.
25. M.G. Banwell, E. Hamel, D.C. Hockless, P. Verdier-Pinard, A.C. Willis, D.J. Wong, 4,5-Diaryl-1H-pyrrole-2-carboxylates as combretastatin A-4/lamellarin T hybrids: Synthesis and evaluation as anti-mitotic and cytotoxic agents, Bioorg. Med. Chem., 2006, 14, 4627-4638.
26. C.P. Ridley, M.V. Reddy, G. Rocha, F.D. Bushman, D.J. Faulkner, Total synthesis and evaluation of lamellarin alpha 20-Sulfate analogues, Bioorg. Med. Chem., 2002, 10, 3285-3290.
27. T. Yamaguchi, T. Fukuda, F. Ishibashi, M. Iwao, The first total synthesis of lamellarin α 20-sulfate, a selective inhibitor of HIV-1 integrase. Tetrahedron, in press.
28. Malumbres, M., and Barbacid, M. Mammalian cyclin-dependent kinases, Trends Biochem. Sci., 2005, 30, 630-641.
29. M. Knockaert, P. Greengard, L. Meijer, Pharmacological inhibitors of cyclin-dependent kinases, Trends Pharmacol. Sci., 2002, 23, 417-425.
30. L. Meijer, M. Flajolet, P. Greengard, Pharmacological inhibitors of glycogen synthase kinase-3, Trends Pharmacol. Sci., 2004, 25, 471-480.
31. M. Bachmann, T. Moroy, The serine/threonine kinase Pim-1, Int. J. Biochem. Cell Biol., 2005, 37, 726-730.
32. J. Galceran, K. de Graaf, F.J. Tejedor, W. Becker, The MNB/DYRK1A protein kinase: genetic and biochemical properties, J. Neural. Transm. Suppl., 2003, 67, 139-148.
33. B. Hammerle, C. Elizalde, J. Galceran, W. Becker, F.J. Tejedor, The MNB/DYRK1A protein kinase: neurobiological functions and Down syndrome implications, J. Neural Transm. Suppl., 2003, 67, 129-137.
34. Ferrer, M. Barrachina, B. Puig, M. Martinez de Lagran, E. Marti, J. Avila, M. Dierssen, Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models, Neurobiol. Dis., 2005, 20, 392-400.
35. U. Knippschild, S. Wolff, G. Giamas, C. Brockschmidt, M. Wittau, P.U. Wurl, T. Eismann, M. Stoter, The role of the casein kinase 1 (CK1) family in different signaling pathways linked to cancer development, Onkologie, 2005, 28, 508-514.
36. F. Ishibashi, Y. Miyazaki, M. Iwao, Total syntheses of lamellarin D and H. The first synthesis of lamellarin-class marine alkaloids, Tetrahedron, 1997, 53, 5951-5962.
37. N. Fujikawa, T. Ohta, T. Yamaguchi, T. Fukuda, F. Ishibashi, M. Iwao, Total synthesis of lamellarin D, L, and N. Tetrahedron, 2006, 62, 594-604.
38. L. Meijer, A. Borgne, O. Mulner, J.P.J. Chong, J.J. Blow, N. Inagaki, M. Inagaki, J.G. Delcros, J.P. Moulinoux, Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5, Eur. J. Biochem., 1997, 24, 527-536.
39. Primot, B. Baratte, M. Gompel, A. Borgne, S. Liabeuf, J.L. Romette, F. Costantini, L. Meijer, Purification of GSK-3 by affinity chromatography on immobilised axin, Protein Expr. & Purif., 2000, 20, 394-404.
40. J. Reinhardt, Y. Ferandin, L. Meijer, Purification CK1 by affinity chromatography on immobilised axin, Protein Expr. & Purif., 2007, 54, 101-109.
41. J. Ribas, J. Boix, Cell differentiation, caspase inhibition, and macromolecular synthesis blockage, but not BCL-2 or BCL-XL proteins, protect SH-SY5Y cells from apoptosis triggered by two CDK inhibitory drugs, Exp. Cell Res., 2004, 295, 9-24.
42. Bettayeb, K., Oumata, N., Echalier, A., Ferandin, Y., Endicott, J., Galons, H. and Meijer, L., 2008. CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases. Oncogene, in press.
43. M. Nguyen, R.C. Marcellus, A. Roulston, M. Watson, L. Serfass, S.R. Murthy Madiraju, D. Goulet, J. Viallet, L. Bélec, X. Billot, S. Acoca, E. Purisima, A. Wiegmans, L. Cluse, R.W. Johnstone, P. Beauparlant, G.C. Shore, Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis, Proc. Natl. Acad. Sci. U.S.A., 2007, 104, 19512-19517.
44. S. Bach, M. Knockaert, O. Lozach, J. Reinhardt, B. Baratte, S. Schmitt, S.P. Coburn, L. Tang, T. Jiang, D.C. Liang, H. Galons, J.F. Dierick, F. Totzke, C. Schächtele, A.S. Lerman, A. Carnero, Y. Wan, N. Gray, L. Meijer, Roscovitine targets: protein kinases and pyridoxal kinase, J. Biol. Chem., 2005, 280, 31208-31219.